Gravar-mail: Re: Ling Y-H, Li T, Yuan Z, Haigentz M, Jr., Weber TK, and Perez-Soler R (2007) Erlotinib, an Effective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces p27(KIP1) Up-Regulation and Nuclear Translocation in Association with Cell Growth Inhibition and G(1)/S Phase Arrest in Human Non-Small-Cell Lung Cancer Cell Lines. Mol Pharmacol 72:248–258; doi:10.1124/mol.107.034827